FindTrial
Sign In

Testing Saliva for SARS-CoV-2

Assessment of swabs and saliva collected by patients for SARS-CoV-2 testing efficiency - SALIVA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/09/027597
Enrollment
100
Registered
2020-09-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Control Intervention1: NIL: NIL

Sponsors

Asian Healthcare Foundation
Lead Sponsor
AIG Hospitals
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with clinical symptoms such as fever, sore throat and cough and who have been admitted in the hospital and tested positive by RT-PCR 2. Patients who can take swab by themselves 3.Patients who can collect saliva 4. Patients who can give informed consent

Exclusion criteria

Exclusion criteria: 1.Patients with clinical symptoms of flu 2.Patients who cannot take swabs by themselves 3.Patients who cannot collect saliva 4. Patients who can give informed consent

Design outcomes

Primary

MeasureTime frame
Simple method of sampling for testing SARS-CoV-2 infectionTimepoint: One month—

Secondary

MeasureTime frame
To test swabs taken by patients themselves to reduce burden on healthcare workersTimepoint: One month—

Countries

India

Contacts

Public ContactDr M Sasikala

Asian Institute of Gastroenterology Hospitals

aigindia@yahoo.co.in04042444222

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026